HUGO MANCO: Open Payments
NPI 1932734985 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 25 payments from 15 companies in 2025. Trend: 2023 $528 · 2024 $901 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $170 |
| Alnylam Pharmaceuticals Inc. | 4 | $74 |
| Novo Nordisk Inc | 2 | $50 |
| Impulse Dynamics (USA) Inc. | 1 | $43 |
| BridgeBio Pharma, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| ENDOTRONIX, INC. | 1 | $31 |
| Amgen Inc. | 2 | $31 |
Products named: CARDIOMEMS, AMVUTTRA, Wegovy, Optimizer, Attruby, VYNDAQEL, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR, REPATHA.
Industry payments across NY — which companies pay providers there.
